LivaNova PLC
LIVN
Classement en actions
#3829
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Prix de l'action
$78.73
Capitalisation boursière
$4.32B
Changement (1 jour)
-1.23%
Changement (1 an)
43.90%
Pays
GB
Échange LivaNova PLC (LIVN)
Catégorie
Healthcare
Ratio P/S pour LivaNova PLC (LIVN)
Ratio P/S au October 2026 TTM : 2.84
Selon les derniers rapports financiers et le cours de l'action de LivaNova PLC, le ratio cours/ventes actuel (TTM) est 2.84. À la fin de 2023, le ratio P/S était de 2.42.
Historique du ratio P/S pour LivaNova PLC de 2000 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 2.84 | 42.01% |
| 2024 | 2.00 | -17.11% |
| 2023 | 2.42 | -16.82% |
| 2022 | 2.91 | -32.02% |
| 2021 | 4.28 | 24.15% |
| 2020 | 3.44 | 2.38% |
| 2019 | 3.36 | -16.06% |
| 2018 | 4.01 | 5.30% |
| 2017 | 3.81 | 110.23% |
| 2016 | 1.81 | -66.32% |
| 2015 | 5.37 | -29.20% |
| 2013 | 7.59 | -14.77% |
| 2012 | 8.91 | -13.53% |
| 2011 | 10.30 | -10.81% |
| 2010 | 11.55 | -10.97% |
| 2009 | 12.97 | -15.16% |
| 2008 | 15.29 | 12.20% |
| 2007 | 13.62 | -3.49% |
| 2006 | 14.12 | -13.13% |
| 2005 | 16.25 | 11.43% |
| 2004 | 14.58 | -1.13% |
| 2003 | 14.75 | -31.71% |
| 2002 | 21.60 | 0.00% |
| 2001 | 0.00 | -100.00% |
| 2000 | 26.35 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 3.82 | 34.67% |
US
|
|
| 2.78 | -1.95% |
IE
|
|
| 4.18 | 47.13% |
US
|
|
| 2.97 | 4.58% |
US
|
|
| - | - |
DE
|
